These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Long-term strategies in the management of heart failure: looking beyond ventricular function and symptoms. Packer M Am J Cardiol; 1992 Jun; 69(18):150G-154G. PubMed ID: 1626488 [TBL] [Abstract][Full Text] [Related]
63. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Jeserich M; Pape L; Just H; Hornig B; Kupfer M; Münzel T; Lohmann A; Olschewski M; Drexler H Am J Cardiol; 1995 Nov; 76(14):1079-82. PubMed ID: 7484869 [TBL] [Abstract][Full Text] [Related]
64. Physiologic basis of vasodilator therapy for heart failure. Cohn JN Am J Med; 1981 Jul; 71(1):135-9. PubMed ID: 7018235 [TBL] [Abstract][Full Text] [Related]
65. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure. Bristow MR; Gilbert EM Eur Heart J; 1995 Jul; 16 Suppl F():20-31. PubMed ID: 8521881 [TBL] [Abstract][Full Text] [Related]
66. [Problems of chronic heart failure]. Tkaczewski W Pol Arch Med Wewn; 1992; 88(2-3):200-6. PubMed ID: 1492027 [No Abstract] [Full Text] [Related]
67. New drugs in the treatment of heart failure. Brown L Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):829-32. PubMed ID: 8593738 [TBL] [Abstract][Full Text] [Related]
68. Changes in the peripheral circulation in heart failure. Drexler H Curr Opin Cardiol; 1995 May; 10(3):268-73. PubMed ID: 7612976 [TBL] [Abstract][Full Text] [Related]
72. The cardiomyopathy of overload: an unnatural growth response. Katz AM Eur Heart J; 1995 Dec; 16 Suppl O():110-4. PubMed ID: 8682075 [TBL] [Abstract][Full Text] [Related]
73. Effects of phosphodiesterase inhibition on skeletal muscle vasculature. LeJemtel TH; Scortichini D; Levitt B; Sonnenblick EH Am J Cardiol; 1989 Jan; 63(2):27A-30A. PubMed ID: 2909994 [TBL] [Abstract][Full Text] [Related]
74. Does aspirin treatment influence vascular resistance and fluid filtration in patients with congestive heart failure? Galatius S; Wroblewski H; Kastrup J Heart; 1999 Mar; 81(3):330. PubMed ID: 10357590 [No Abstract] [Full Text] [Related]
75. Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Tan LB Cardiovasc Res; 1987 Aug; 21(8):615-22. PubMed ID: 3328649 [TBL] [Abstract][Full Text] [Related]
76. Local control of human peripheral vascular tone: implications for drug therapy. Benjamin N; Vallance P Clin Sci (Lond); 1991 Mar; 80(3):183-90. PubMed ID: 1850676 [No Abstract] [Full Text] [Related]
77. Effect on peripheral arterioles of chronic fluid and sodium retention in heart failure. Wilson JR; Lanoce V; Frey MJ; Ferraro N J Am Coll Cardiol; 1988 Jul; 12(1):202-8. PubMed ID: 3379206 [TBL] [Abstract][Full Text] [Related]
78. Heart failure in 2001: a prophecy. Katz AM Am J Cardiol; 1992 Oct; 70(10):126C-131C. PubMed ID: 1414889 [TBL] [Abstract][Full Text] [Related]
79. [Peripheral adaptation in chronic heart failure: therapeutic implications]. Drexler H Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301 [TBL] [Abstract][Full Text] [Related]
80. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors? Münzel T; Kurz S; Drexler H Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]